MICROPORT SCIENTIFIC CORPORATION Financials MicroPort Scientific Corporation
Equities
853
KYG608371046
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 HKD | +1.30% |
|
-5.67% | -44.66% |
| 08-30 | MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
| 08-23 | MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical | MT |
Projected Income Statement: MicroPort Scientific Corporation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 793.5 | 648.7 | 778.6 | 840.8 | 950.7 | 1,150 | 1,346 | 1,605 |
| Change | - | -18.24% | 20.02% | 7.99% | 13.07% | 20.93% | 17.07% | 19.24% |
| EBITDA 1 | 89.64 | -96.74 | -211.1 | -374.6 | -384.6 | 30.5 | 54.43 | 319.3 |
| Change | - | - | 118.24% | 77.41% | 2.69% | - | 78.47% | 486.62% |
| EBIT 1 | 28.46 | -167.6 | -293.6 | -507 | -516.2 | -124.4 | 8.39 | 110.4 |
| Change | - | - | 75.23% | 72.66% | 1.82% | 75.89% | - | 1,216.11% |
| Interest Paid 1 | -22.7 | -39.71 | -47.88 | -74.52 | -96.04 | -120.3 | -117.1 | -111 |
| Earnings before Tax (EBT) 1 | 63.21 | -212.9 | -337.3 | -581.5 | -626.5 | -260 | -242.9 | -19.82 |
| Change | - | - | 58.41% | 72.39% | 7.74% | 58.51% | 6.55% | 91.84% |
| Net income 1 | 46.28 | -191.3 | -276.5 | -436.5 | -477.6 | -185.7 | -154.6 | 38.76 |
| Change | - | - | 44.57% | 57.88% | 9.42% | 61.11% | 16.79% | - |
| Announcement Date | 30/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 28/03/24 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: MicroPort Scientific Corporation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 178 | -706 | -511 | 88.6 | 547 | 323 | 49.1 | - |
| Change | - | -496.63% | -172.38% | -82.66% | 517.38% | -40.95% | -84.8% | - |
| Announcement Date | 30/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 28/03/24 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: MicroPort Scientific Corporation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 97.04 | 103.5 | 247.9 | 263.3 | 166.7 | 167.5 | 126 | 140 |
| Change | - | 6.67% | 139.48% | 6.2% | -36.67% | 0.47% | -24.78% | 11.11% |
| Free Cash Flow (FCF) 1 | -70.59 | -126.7 | -479.3 | -606.6 | -429.9 | -264 | -250.7 | 96 |
| Change | - | 79.5% | 278.24% | 26.56% | -29.13% | -38.59% | -5.05% | -138.3% |
| Announcement Date | 30/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 28/03/24 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: MicroPort Scientific Corporation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 11.3% | -14.91% | -27.12% | -44.55% | -40.46% | 2.65% | 4.04% | 19.9% |
| EBIT Margin (%) | 3.59% | -25.83% | -37.71% | -60.29% | -54.29% | -10.82% | 0.62% | 6.88% |
| EBT Margin (%) | 7.97% | -32.82% | -43.32% | -69.16% | -65.9% | -22.61% | -18.05% | -1.23% |
| Net margin (%) | 5.83% | -29.48% | -35.51% | -51.91% | -50.24% | -16.16% | -11.48% | 2.42% |
| FCF margin (%) | -8.9% | -19.53% | -61.55% | -72.14% | -45.22% | -22.96% | -18.62% | 5.98% |
| FCF / Net Income (%) | -152.53% | 66.25% | 173.35% | 138.96% | 90.01% | 142.13% | 162.19% | 247.67% |
Profitability | ||||||||
| ROA | 3.22% | -9.4% | -8.07% | -10.42% | -12.05% | -4.88% | -2.01% | 1.9% |
| ROE | 9.62% | -23.22% | -21.12% | -33.25% | -50.47% | -25.17% | -14.51% | 7.64% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | 1.99x | - | - | -0.24x | -1.42x | 10.61x | 0.9x | - |
| Debt / Free cash flow | -2.52x | - | - | -0.15x | -1.27x | -1.23x | -0.2x | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 12.23% | 15.96% | 31.84% | 31.31% | 17.54% | 14.57% | 9.36% | 8.72% |
| CAPEX / EBITDA (%) | 108.26% | -107% | -117.41% | -70.29% | -43.35% | 549.2% | 231.48% | 43.84% |
| CAPEX / FCF (%) | -137.47% | -81.69% | -51.72% | -43.4% | -38.78% | -63.45% | -50.27% | 145.83% |
Items per share | ||||||||
| Cash flow per share 1 | 0.0158 | -0.0129 | -0.142 | -0.1888 | -0.1271 | -0.09 | -0.01 | 0.06 |
| Change | - | -181.65% | 1,001.16% | 32.91% | -32.68% | -29.19% | -88.89% | -700% |
| Dividend per Share 1 | 0.00684 | 0.00553 | 0.00549 | - | - | - | - | - |
| Change | - | -19.15% | -0.72% | - | - | - | - | - |
| Book Value Per Share 1 | 0.3277 | 0.63 | 0.8244 | 0.622 | 0.4155 | 0.3525 | 0.3775 | 0.32 |
| Change | - | 92.25% | 30.86% | -24.55% | -33.2% | -15.16% | 7.09% | -15.23% |
| EPS 1 | 0.0198 | -0.1097 | -0.1654 | -0.2408 | -0.2619 | -0.101 | -0.0767 | 0.0208 |
| Change | - | -654.04% | 50.77% | 45.59% | 8.76% | -61.43% | -24.03% | -127.09% |
| Nbr of stocks (in thousands) | 1,616,587 | 1,783,923 | 1,794,276 | 1,821,352 | 1,831,722 | 1,834,820 | 1,834,820 | 1,834,820 |
| Announcement Date | 30/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 28/03/24 | - | - | - |
1USD
Estimates
| 2024 * | 2025 * | |
|---|---|---|
| P/E ratio | -5.92x | -7.79x |
| PBR | 1.7x | 1.58x |
| EV / Sales | 1.24x | 0.85x |
| Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
0.5978USD
Average target price
1.424USD
Spread / Average Target
+138.24%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 853 Stock
- Financials MicroPort Scientific Corporation
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition